M35.3 Polymyalgia rheumatica

Name of the Condition

• Polymyalgia Rheumatica

Summary

Polymyalgia rheumatica is an inflammatory disorder characterized by muscle pain and stiffness, primarily affecting the shoulders, neck, and hips. It typically occurs in older adults and is often associated with elevated inflammatory markers. The condition may coexist with giant cell arteritis, a related vasculitis.

Causes

The exact cause is unknown, but it is believed to involve autoimmune mechanisms where the immune system triggers inflammation in affected tissues. Genetic predisposition and environmental factors are suspected contributors, though specific triggers remain unclear.

Risk Factors

• Age: Most common in individuals over 50, with peak incidence in those aged 70–80.
• Gender: More prevalent in women than men.
• Geographic Region: Higher incidence in Northern European populations.
• Associated Conditions: May occur alongside giant cell arteritis or other autoimmune diseases.

Symptoms

• Morning stiffness lasting 30 minutes or longer, especially in the shoulders, hips, or neck.
• Aching or pain in affected muscle groups, often bilateral and symmetric.
• Fatigue and low-grade fever.
• Unintentional weight loss or loss of appetite in some cases.

Diagnosis

Diagnosis is based on clinical evaluation, including history and physical examination. Laboratory tests typically show elevated inflammatory markers (e.g., erythrocyte sedimentation rate, C-reactive protein). Imaging may be used to rule out other conditions, and giant cell arteritis screening is recommended due to potential overlap.

Treatment Options

• Corticosteroids: First-line therapy to reduce inflammation and relieve symptoms.
• Monitoring: Regular follow-up to adjust medication and monitor for side effects.
• Adjunct Therapies: Low-dose steroids may be tapered gradually based on response.
• Giant Cell Arteritis Screening: If symptoms suggest overlap, temporal artery biopsy or imaging may be performed.

Prognosis and Follow-Up

Most patients respond well to treatment, with symptoms improving within days to weeks. Relapse may occur if steroids are tapered too quickly. Long-term follow-up is necessary to manage medication side effects and monitor for associated conditions like giant cell arteritis.

Complications

• Giant Cell Arteritis: A serious complication involving inflammation of blood vessels, potentially leading to vision loss.
• Steroid Side Effects: Prolonged use may cause osteoporosis, diabetes, or hypertension.
• Muscle Weakness: Persistent symptoms if treatment is inadequate.

Lifestyle & Prevention

• Gentle Exercise: Low-impact activities to maintain mobility and reduce stiffness.
• Balanced Diet: Adequate calcium and vitamin D to support bone health during steroid therapy.
• Regular Monitoring: Routine check-ups to address medication-related risks.

When to Seek Professional Help

Seek care if symptoms worsen, new vision changes occur, or steroid side effects (e.g., severe pain, unexplained weight gain) develop. Immediate evaluation is needed for signs of giant cell arteritis, such as headache or jaw claudication.

Tips for Medical Coders

• Document clinical findings supporting polymyalgia rheumatica, including symptom duration, affected areas, and inflammatory marker results.
• Note any associated conditions like giant cell arteritis, as these may require additional coding.
• Ensure documentation aligns with ICD-10-CM guidelines for M35.3, avoiding assumptions about unrelated symptoms or comorbidities.